Searched for
SANOFI HEALTHCARE INDIA
Dividend alert! Last day to buy HDFC Bank, Tata Motors PV, 14 other stocks for dividends worth Rs 248Under SEBI's T+1 settlement cycle, investors must purchase a company's shares at least one trading day before the record date to ensure the...- Dividends and bonus issues: 31 stocks turning ex-record date this week. Do you own any?As many as 31 companies, including HDFC Bank, Tata group firms and Brigade Enterprises, will turn ex-record date for dividends and bonus is...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- Bonus issue, stock split, dividend: 9 stocks to turn ex-record date next week, check detailsRail Vikas Nigam Limited shares rose 6% after securing a ₹967 crore railway order, strengthening its order book and boosting investor senti...
- Sunil Singhania-backed Abakkus Small Cap Fund first portfolio out since NFO; 42 stocks held, Karur Vysya Bank top betSunil Singhania backed Abakkus Mutual Fund has unveiled the maiden portfolio of its smallcap fund - Abakkus Small Cap Fund, following an in...
- Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75Sanofi Consumer Healthcare shares surged over 14% following a robust 50% year-on-year net profit increase to Rs 66.5 crore in Q4. Driven by...
- Sanofi Health leases office space in Hyderabad"The monthly rental is set at ?75 per sq ft, amounting to a total of ?2.05 crore. A security deposit equivalent to 7.5 months of rent, valu...
- CD&R makes Rs 2,983 cr open offer for 26% stake in Sanofi Consumer Healthcare IndiaGlobal investment firm CD&R announces an open offer to acquire a 26% stake in Sanofi Consumer Healthcare India for up to Rs 2,983 crore. Th...
- Dispute with Sanofi settled, Panacea scrip soars to over 3-yr highPanacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involve...
- Panacea, Sanofi settle patent litigation over hexavalent vaccinePanacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not launch its Sh...
- Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
- Sanofi to invest Euro 400 mn in its Hyderabad GCC by 2030Sanofi Healthcare India Pvt Ltd plans to invest €400 million in its Hyderabad Global Capacity Centre (GCC) over six years, including €100 m...
- Sanofi looks for accelerated growth in India; plans fast-tracking of product pipelineSanofi, a leading French pharmaceutical company, aims to expand its presence in the Indian market by introducing new drugs, enhancing local...
- Dr Reddy's to promote, distribute Sanofi vaccine brands in IndiaThe announcement comes a day after Sanofi Healthcare India announced a separate partnership with Cipla to boost access to Sanofi's central ...
- Cipla to distribute Sanofi's CNS product line in IndiaAccording to the joint statement, Cipla will utilise its skills and solid India-wide network of distributors, institutions and market outre...
- Sanofi India board OKs demerger of consumer health businessDrug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer healthcare business into a separate entity. Th...
- Sanofi board approves demerger of its consumer healthcare businessThis decision will open new gates for the India business and employees in a value-driven move to accelerate growth for both the pharmaceuti...
- Sanofi, Boehringer Ingelheim close business swap in IndiaSanofi is excited to embrace the incoming CHC brands and people associated with this business, as this is in line with objective of boostin...
- Sanofi Aventis's Piramal plans fall throughFrench pharma major Sanofi Aventis's plans to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through due to differe...
- Sanofi seen ahead in Piramal raceSanofi-Aventis has completed due diligence and the deal could be closed soon, one of the two persons told ET on condition of anonymity.
Load More
